In addition, it has to be noted that the glucose-dependent insulinotropic polypeptide (GIP) has recently gained renewed interest for the treatment of diabetes due to the clinical success of the GIP/GLP-1 coagonist tirzepatide (18). This evidence concerns the gene GIP and diabetes mellitus.